Thanks to visit codestin.com
Credit goes to github.com

Skip to content

Build a knowledge graph connecting variants, drugs, and clinical evidence to identify therapeutic opportunities (e.g. CIViC - Clinical Interpretations of Variants in Cancer)

License

Notifications You must be signed in to change notification settings

collaborativebioinformatics/GeNETwork

 
 

Repository files navigation

GeNETwork

How to Install

Prerequisites

Dependencies

AWS Configuration


Background

Analysis target: Pediatric cancers, which have historically been underserved in terms of therapeutic development and clinical trials, as drug companies were not previously required to study pediatric cancers. Most pediatric therapeutic discovery is done by pediatrics researchers, not drug companies. The FDA's Pediatric Molecular Target List is a list of genes that pediatric clinician experts have outlined as critical to address to treat pediatric cancer. The RACE for Children Act (USA, https://www.congress.gov/bill/115th-congress/house-bill/1231) recently made it a rule that if an actionable mutation or gene for an adult cancer is being targeted by pharma/biotech, and if that target is in the PMTL,then the company must justify why they are not testing it or they must trial the drug in children.

Basing this project therefore on pediatric cancers, where the data has been harmonized for the Molecular Targets Project (MTP: https://moleculartargets.ccdi.cancer.gov/) and the FDA PMTL https://moleculartargets.ccdi.cancer.gov/fda-pmtl

The Molecular Targets Project's data was produced at the Children's Hospital of Philadelphia with aligned RNA and DNA sequence data by the Kids First Data Resource Center from Kids First, TARGET and other pediatric cancer datasets. The data was all harmonized with the OpenPedCan suite of tools https://github.com/d3b-center/OpenPedCan-analysis cited here: https://pubmed.ncbi.nlm.nih.gov/39026781/ and used in the MTP website.

Nodes for this KG: genes, diseases, drugs, pathway names etc. Edges: relationships.

Order of operations: Ingestion of GENCODE or HGNC, then CIVIC, then PMTL, then aggregated somatic variant data from Kids First/TARGET (as part of the molecular targets project, see above). Also aggregated somatic variant data from TCGA if available (by cancer/cohort).


Overview

We call this ATLAS_KG: the Actionable Therapeutics Linkage for Age-Stratified cancers Knowledge Graph. Like a geographic atlas helps you navigate terrain, ATLAS_KG helps navigate the landscape of therapeutic opportunities connecting adult and pediatric cancer precision medicine.


Methods

This project builds a knowledge graph integrating pediatric and adult cancer data to answer multiple queries including identifying repurposing opportunities mandated by the RACE for Children Act.

Data Sources

Source Purpose Access
Molecular Targets Project Pediatric Molecular targets and PMTL Link
TCGA Adult Cancer Somatic Mutations
CIViC Clinical variant interpretations Link
OncoDB Drug-target interactions
MSigDB Pathway gene sets
HGNC Gene nomenclature standardization
StringDB Protein-protein interactions

Flowchart

Live version of the below image is at https://excalidraw.com/#room=84a47bb70689327cd820,B6WRlwllBajvdws7goQYjg FlowChart

Knowledge Graph Schema

KGSchema

Data Processing Pipeline

  1. Data Acquisition (OSF/S3??)
  2. Preprocessing: StringDB will be
  3. Graph Construction: Data transformed to triples and loaded into AWS Neptune. StringDB will be added to ensure network connectivity.
  4. Quality Control

About

Build a knowledge graph connecting variants, drugs, and clinical evidence to identify therapeutic opportunities (e.g. CIViC - Clinical Interpretations of Variants in Cancer)

Resources

License

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published

Contributors 9